Interview with President & CEO of RepliCel Life Sciences, Lee Buckler

RepliCel Life Science is a Vancouver based biotech company focused on aesthetics and orthopedics, developing tailor-made products to restore cellular function to rejuvenate aging or sun damaged skin, regrow hair, and repair tendons.  RepliCel’s cell therapy product candidate pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RepliCel's three cell therapy product candidates have now been tested in over 100 patients in four countries on three continents and successfully reviewed by three different regulatory agencies. RepliCel has also developed a proprietary injection device, RCI-02, optimized for the administration of its products and licensable for use with other dermatology applications.